drugset / Trial / NCT03015324

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

NCT03015324

Phase 1 Completed 38 enrolled Peng Wang, MD PhD
NaSingle-groupOpen-labelTreatment

Summary

Hydroxychloroquine will be administered on an outpatient basis within 12 weeks after primary surgery followed by adjuvant chemotherapy /or radiation therapy (if needed). Hydroxychloroquine will be administered orally at a dose of 400 mg daily for 90 days. Subjects will receive HCQ every day.

Timeline

Start
2017-08-08
Primary completion
2020-02-03
Completion
2021-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg Oral

Indications